Marta Saracco

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

Suzana Jordan, Jörg H. W. Distler, Britta Maurer et al. · Annals of the Rheumatic Diseases · 2014 · 428 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani et al. · Journal of Translational Medicine · 2020 · 112 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis

Luca Quartuccio, Martina Fabris, S. Salvin et al. · Lara D. Veeken · 2009 · 95 citations

Medicine, Internal Medicine, Pharmacotherapy +16

The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study

Luca Quartuccio, Martina Fabris, Elena Pontarini et al. · Annals of the Rheumatic Diseases · 2013 · 70 citations

Life Sciences, Immunology, Internal Medicine +17

Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis

Alarico Ariani, Mario Silva, Valeria Seletti et al. · Lara D. Veeken · 2016 · 40 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17